{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:07:57Z","timestamp":1784164077818,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["07330462210007"],"award-info":[{"award-number":["07330462210007"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003607","name":"Association for Frontotemporal Degeneration","doi-asserted-by":"publisher","award":["2024-005"],"award-info":[{"award-number":["2024-005"]}],"id":[{"id":"10.13039\/100003607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022722","name":"GIESKES-STRIJBIS FONDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.09-2022-05"],"award-info":[{"award-number":["WE.09-2022-05"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum. Genet."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The majority of individuals at 50% risk of carrying a pathogenic variant causing frontotemporal dementia (FTD) chooses not to undergo presymptomatic genetic testing. To explore reasons of individuals at risk of genetic FTD for and against genetic testing, we conducted a secondary analysis of semi-structured interviews with 28 Dutch individuals at risk of genetic FTD: 11 carriers, three non-carriers and 14 individuals at 50% risk. We analyzed the data using inductive thematic analysis. Reasons in favor of presymptomatic genetic testing included wanting to know and relieving uncertainty, hoping to test negative, relevance for life planning, reproductive decision-making, explaining future symptoms, and contributing to the common good. Reasons against presymptomatic genetic testing were fearing psychological impact, fearing effects on employment, insurability or mortgage, maintaining hope, and no immediate relevance for life planning, partly due to uncertainty surrounding age of onset. Reasons were similar in all groups, but were weighed differently. Decision-making processes were influenced by (expectations of) psychological burden before and after testing, personal experiences with FTD in the family, and whether genetic status was perceived as actionable. Perceived relevance was partly influenced by age (in relation to age of onset), life circumstances and research participation. When supporting individuals at risk of FTD in decision-making regarding genetic testing, genetic counselors should be aware of and tailor counseling to the individual\u2019s age and lived experience with being at risk, experiences with FTD and related disorders in the family, and factors influencing the perceived relevance of genetic status for reproductive or life decision-making.<\/jats:p>","DOI":"10.1007\/s00439-025-02795-1","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:52:55Z","timestamp":1771246375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reasons for and against presymptomatic genetic testing in frontotemporal dementia: a qualitative study"],"prefix":"10.1007","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2178-0032","authenticated-orcid":false,"given":"Charlotte H.","family":"Graafland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-7527","authenticated-orcid":false,"given":"Harro","family":"Seelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-6555","authenticated-orcid":false,"given":"Jessica L.","family":"Panman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6278-6844","authenticated-orcid":false,"given":"John C.","family":"van Swieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-6222","authenticated-orcid":false,"given":"Eline M.","family":"Bunnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2436-0931","authenticated-orcid":false,"given":"Laura","family":"Donker Kaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"1","key":"2795_CR1","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000538","volume":"7","author":"MDM Amador","year":"2020","unstructured":"Amador MDM, Gargiulo M, Boucher C et al (2020) Who and Why? Requests for presymptomatic genetic testing for amyotrophic lateral sclerosis\/frontotemporal dementia vs Huntington disease. Neurol Genet 7(1):e538. https:\/\/doi.org\/10.1212\/NXG.0000000000000538","journal-title":"Neurol Genet"},{"issue":"1","key":"2795_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/cge.13529","volume":"96","author":"KE Anderson","year":"2019","unstructured":"Anderson KE, Eberly S, Marder KS et al (2019) The choice not to undergo genetic testing for Huntington disease: results from the PHAROS study. Clin Genet 96(1):28\u201334. https:\/\/doi.org\/10.1111\/cge.13529","journal-title":"Clin Genet"},{"issue":"24","key":"2795_CR3","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1212\/WNL.0000000000002773","volume":"86","author":"M Benatar","year":"2016","unstructured":"Benatar M, Stanislaw C, Reyes E et al (2016) Presymptomatic ALS genetic counseling and testing: experience and recommendations. Neurology 86(24):2295\u20132302. https:\/\/doi.org\/10.1212\/WNL.0000000000002773","journal-title":"Neurology"},{"key":"2795_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00171","volume":"7","author":"A Benussi","year":"2015","unstructured":"Benussi A, Padovani A, Borroni B (2015) Phenotypic heterogeneity of monogenic frontotemporal dementia. Front Aging Neurosci 7:171. https:\/\/doi.org\/10.3389\/fnagi.2015.00171","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"2795_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1399-0004.1998.tb03768.x","volume":"54","author":"J Binedell","year":"1998","unstructured":"Binedell J, Soldan JR, Harper PS (1998a) Predictive testing for Huntington\u2019s disease: I. Predictors of uptake in South Wales. Clin Genet 54(6):477\u2013488. https:\/\/doi.org\/10.1111\/j.1399-0004.1998.tb03768.x","journal-title":"Clin Genet"},{"issue":"6","key":"2795_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1399-0004.1998.tb03769.x","volume":"54","author":"J Binedell","year":"1998","unstructured":"Binedell J, Soldan JR, Harper PS (1998b) Predictive testing for Huntington\u2019s disease: II. Qualitative findings from a study of uptake in South Wales. Clin Genet 54(6):489\u2013496. https:\/\/doi.org\/10.1111\/j.1399-0004.1998.tb03769.x","journal-title":"Clin Genet"},{"issue":"2","key":"2795_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa","journal-title":"Qual Res Psychol"},{"issue":"2","key":"2795_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/13607863.2020.1857697","volume":"26","author":"J Bruinsma","year":"2022","unstructured":"Bruinsma J, Peetoom K, Bakker C, Boots L, Verhey F, de Vugt M (2022) \u2018They simply do not understand\u2019: a focus group study exploring the lived experiences of family caregivers of people with frontotemporal dementia. Aging Ment Health 26(2):277\u2013285. https:\/\/doi.org\/10.1080\/13607863.2020.1857697","journal-title":"Aging Ment Health"},{"issue":"6","key":"2795_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/13543784.2024.2349286","volume":"33","author":"FR Buccellato","year":"2024","unstructured":"Buccellato FR, D\u2019Anca M, Tartaglia GM, Del Fabbro M, Galimberti D (2024) Frontotemporal dementia: from genetics to therapeutic approaches. Expert Opin Investig Drugs 33(6):561\u2013573. https:\/\/doi.org\/10.1080\/13543784.2024.2349286","journal-title":"Expert Opin Investig Drugs"},{"key":"2795_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijnurstu.2015.10.016","volume":"55","author":"BA Caceres","year":"2016","unstructured":"Caceres BA, Frank MO, Jun J, Martelly MT, Sadarangani T, de Sales PC (2016) Family caregivers of patients with frontotemporal dementia: an integrative review. Int J Nurs Stud 55:71\u201384. https:\/\/doi.org\/10.1016\/j.ijnurstu.2015.10.016","journal-title":"Int J Nurs Stud"},{"issue":"7\u20138","key":"2795_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/21678421.2017.1332079","volume":"18","author":"A Crook","year":"2017","unstructured":"Crook A, Williams K, Adams L, Blair I, Rowe DB (2017) Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations. Amyotroph Lateral Scler Front Degener 18(7\u20138):475\u2013485. https:\/\/doi.org\/10.1080\/21678421.2017.1332079","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"4","key":"2795_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/WAD.0000000000000458","volume":"35","author":"A Crook","year":"2021","unstructured":"Crook A, Jacobs C, Newton-John T, Richardson E, McEwen A (2021) Patient and relative experiences and decision-making about genetic testing and counseling for familial ALS and FTD: a systematic scoping review. Alzheimer Dis Assoc Disord 35(4):374\u2013385. https:\/\/doi.org\/10.1097\/WAD.0000000000000458","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"2795_CR13","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1212\/wnl.0000000000000583","volume":"83","author":"EGP Dopper","year":"2014","unstructured":"Dopper EGP, Rombouts SARB, Jiskoot LC et al (2014) Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia. Neurology 83(2):e19-26. https:\/\/doi.org\/10.1212\/wnl.0000000000000583","journal-title":"Neurology"},{"issue":"3","key":"2795_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/jgc4.1749","volume":"33","author":"L Dratch","year":"2024","unstructured":"Dratch L, Owczarzak J, Mu W et al (2024) The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosis. J Genet Couns 33(3):515\u2013527. https:\/\/doi.org\/10.1002\/jgc4.1749","journal-title":"J Genet Couns"},{"issue":"1","key":"2795_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/gte.2006.10.60","volume":"10","author":"H Etchegary","year":"2006","unstructured":"Etchegary H (2006) Genetic testing for Huntington\u2019s disease: how is the decision taken? Genet Test 10(1):60\u201367. https:\/\/doi.org\/10.1089\/gte.2006.10.60","journal-title":"Genet Test"},{"issue":"1","key":"2795_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.2000","volume":"34","author":"N Fahy","year":"2025","unstructured":"Fahy N, Hayes OS, Greaves CV et al (2025) The experience of \u201cat-risk\u201d status for familial frontotemporal dementia (fFTD) and its impact on reproductive decision-making: a qualitative study. J Genet Couns 34(1):e2000. https:\/\/doi.org\/10.1002\/jgc4.2000","journal-title":"J Genet Couns"},{"issue":"4","key":"2795_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/GIM.0b013e318204d004","volume":"13","author":"JH Fanos","year":"2011","unstructured":"Fanos JH, Gronka S, Wuu J, Stanislaw C, Andersen PM, Benatar M (2011) Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis. Genet Med 13(4):342\u2013348. https:\/\/doi.org\/10.1097\/GIM.0b013e318204d004","journal-title":"Genet Med"},{"issue":"3","key":"2795_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ajmg.a.30178","volume":"129A","author":"JH Fanos","year":"2004","unstructured":"Fanos JH, Gelinas DF, Miller RG (2004) \u201cYou have shown me my end\u201d: attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis. Am J Med Genet A 129A(3):248\u2013253. https:\/\/doi.org\/10.1002\/ajmg.a.30178","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2795_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01749-z","volume":"17","author":"CH Graafland","year":"2025","unstructured":"Graafland CH, Seelaar H, Panman JL et al (2025) It seems enormously valuable to me.\" Perspectives of Dutch (potential) carriers of genetic FTD on onset-predictive biomarker testing. Alzheimers Res Ther 17(1):99. https:\/\/doi.org\/10.1186\/s13195-025-01749-z","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"2795_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/14713012221148527","volume":"22","author":"S Gray","year":"2023","unstructured":"Gray S, Shepherd A, Robertson J (2023) Living with a diagnosis of frontotemporal dementia: an interpretative phenomenological analysis. Dementia (London) 22(3):514\u2013532. https:\/\/doi.org\/10.1177\/14713012221148527","journal-title":"Dementia (London)"},{"key":"2795_CR21","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","volume":"266","author":"CV Greaves","year":"2019","unstructured":"Greaves CV, Rohrer JD (2019) An update on genetic frontotemporal dementia. J Neurol 266:2075\u20132086. https:\/\/doi.org\/10.1007\/s00415-019-09363-4","journal-title":"J Neurol"},{"issue":"6","key":"2795_CR22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1177\/1471301214568164","volume":"15","author":"J Griffin","year":"2016","unstructured":"Griffin J, Oyebode JR, Allen J (2016) Living with a diagnosis of behavioural-variant frontotemporal dementia: the person\u2019s experience. Dementia (London) 15(6):1622\u20131642. https:\/\/doi.org\/10.1177\/1471301214568164","journal-title":"Dementia (London)"},{"issue":"1","key":"2795_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation and variability. Field Methods 18(1):59\u201382. https:\/\/doi.org\/10.1177\/1525822X05279903","journal-title":"Field Methods"},{"issue":"9","key":"2795_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/jnnp.74.9.1206","volume":"74","author":"RJ Harvey","year":"2003","unstructured":"Harvey RJ, Skelton-Robinson M, Rossor MN (2003) The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74(9):1206\u20131209. https:\/\/doi.org\/10.1136\/jnnp.74.9.1206","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2795_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/GIM.0b013e3180653c5a","volume":"9","author":"R Klitzman","year":"2007","unstructured":"Klitzman R, Thorne D, Williamson J, Marder K (2007) The roles of family members, health care workers, and others in decision-making processes about genetic testing among individuals at risk for Huntington disease. Genet Med 9(6):358\u2013371. https:\/\/doi.org\/10.1097\/GIM.0b013e3180653c5a","journal-title":"Genet Med"},{"issue":"3","key":"2795_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","volume":"83","author":"R MacLeod","year":"2013","unstructured":"MacLeod R, Tibben A, Frontali M et al (2013) Recommendations for the predictive genetic test in Huntington\u2019s disease. Clin Genet 83(3):221\u2013231. https:\/\/doi.org\/10.1111\/j.1399-0004.2012.01900.x","journal-title":"Clin Genet"},{"issue":"2","key":"2795_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ajmg.1320260205","volume":"26","author":"C Mastromauro","year":"1987","unstructured":"Mastromauro C, Myers RH, Berkman B (1987) Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 26(2):271\u2013282. https:\/\/doi.org\/10.1002\/ajmg.1320260205","journal-title":"Am J Med Genet"},{"issue":"2","key":"2795_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajmg.1320260206","volume":"26","author":"GJ Meissen","year":"1987","unstructured":"Meissen GJ, Berchek RL (1987) Intended use of predictive testing by those at risk for Huntington disease. Am J Med Genet 26(2):283\u2013293. https:\/\/doi.org\/10.1002\/ajmg.1320260206","journal-title":"Am J Med Genet"},{"issue":"3","key":"2795_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1399-0004.2010.01538.x","volume":"80","author":"PJ Morrison","year":"2011","unstructured":"Morrison PJ, Harding-Lester S, Bradley A (2011) Uptake of Huntington disease predictive testing in a complete population. Clin Genet 80(3):281\u2013286. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01538.x","journal-title":"Clin Genet"},{"issue":"3","key":"2795_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/brain\/awl367","volume":"130","author":"FM O'Keeffe","year":"2007","unstructured":"O\u2019Keeffe FM, Murray B, Coen RF et al (2007) Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy. Brain 130(3):753\u2013764. https:\/\/doi.org\/10.1093\/brain\/awl367","journal-title":"Brain"},{"issue":"3","key":"2795_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.gerinurse.2018.10.006","volume":"40","author":"H Rasmussen","year":"2019","unstructured":"Rasmussen H, Hellzen O, Stordal E, Enmarker I (2019) Family caregivers experiences of the pre-diagnostic stage in frontotemporal dementia. Geriatr Nurs 40(3):246\u2013251. https:\/\/doi.org\/10.1016\/j.gerinurse.2018.10.006","journal-title":"Geriatr Nurs"},{"issue":"4","key":"2795_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10897-009-9222-3","volume":"18","author":"SR Riedijk","year":"2009","unstructured":"Riedijk SR, Niermeijer MF, Dooijes D, Tibben A (2009) A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing. J Genet Couns 18(4):350\u2013356. https:\/\/doi.org\/10.1007\/s10897-009-9222-3","journal-title":"J Genet Couns"},{"issue":"6","key":"2795_CR33","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10897-015-9840-x","volume":"24","author":"J Rivera-Navarro","year":"2015","unstructured":"Rivera-Navarro J, Cubo E, Mariscal N (2015) Analysis of the reasons for non-uptake of predictive testing for Huntington\u2019s disease in Spain: a qualitative study. J Genet Couns 24(6):1011\u20131021. https:\/\/doi.org\/10.1007\/s10897-015-9840-x","journal-title":"J Genet Couns"},{"issue":"5","key":"2795_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s10897-013-9678-z","volume":"23","author":"TM Scuffham","year":"2014","unstructured":"Scuffham TM, MacMillan JC (2014) Huntington disease: who seeks presymptomatic genetic testing, why and what are the outcomes? J Genet Couns 23(5):754\u2013761. https:\/\/doi.org\/10.1007\/s10897-013-9678-z","journal-title":"J Genet Couns"},{"issue":"5","key":"2795_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","volume":"82","author":"H Seelaar","year":"2011","unstructured":"Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82(5):476\u2013486. https:\/\/doi.org\/10.1136\/jnnp.2010.212225","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2795_CR36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s10897-015-9819-7","volume":"24","author":"A Surampalli","year":"2015","unstructured":"Surampalli A, Khare M, Kubrussi G et al (2015) Psychological impact of predictive genetic testing in VCP inclusion body myopathy, Paget disease of bone and frontotemporal dementia. J Genet Couns 24(5):842\u2013850. https:\/\/doi.org\/10.1007\/s10897-015-9819-7","journal-title":"J Genet Couns"},{"issue":"1","key":"2795_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/jmg.34.1.63","volume":"34","author":"A Tibben","year":"1997","unstructured":"Tibben A, Stevens M, de Wert GM, Niermeijer MF, van Duijn CM, van Swieten JC (1997) Preparing for presymptomatic DNA testing for early onset Alzheimer\u2019s disease\/cerebral haemorrhage and hereditary Pick disease. J Med Genet 34(1):63\u201372. https:\/\/doi.org\/10.1136\/jmg.34.1.63","journal-title":"J Med Genet"},{"issue":"6","key":"2795_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349\u2013357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Qual Health Care"},{"issue":"9","key":"2795_CR39","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1017\/S1041610211001013","volume":"23","author":"D van Vliet","year":"2011","unstructured":"van Vliet D, de Vugt ME, Bakker C et al (2011) Caregivers\u2019 perspectives on the pre-diagnostic period in early onset dementia: a long and winding road. Int Psychogeriatr 23(9):1393\u20131404. https:\/\/doi.org\/10.1017\/S1041610211001013","journal-title":"Int Psychogeriatr"},{"issue":"12","key":"2795_CR40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/imj.12176","volume":"43","author":"S Wedderburn","year":"2013","unstructured":"Wedderburn S, Panegyres PK, Andrew S et al (2013) Predictive gene testing for Huntington disease and other neurodegenerative disorders. Intern Med J 43(12):1272\u20131279. https:\/\/doi.org\/10.1111\/imj.12176","journal-title":"Intern Med J"},{"issue":"5","key":"2795_CR41","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1089\/gtmb.2010.0065","volume":"14","author":"JK Williams","year":"2010","unstructured":"Williams JK, Erwin C, Juhl A et al (2010) Personal factors associated with reported benefits of Huntington disease family history or genetic testing. Genet Test Mol Biomarkers 14(5):629\u2013636. https:\/\/doi.org\/10.1089\/gtmb.2010.0065","journal-title":"Genet Test Mol Biomarkers"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-025-02795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00439-025-02795-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-025-02795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:19:39Z","timestamp":1781633979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00439-025-02795-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1007\/s00439-025-02795-1","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research protocol was approved by the Research Ethics Review Committee of Erasmus MC [ref. MEC-2023\u20130375] and conforms with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participants were provided with the Participant Information Form when they were interested in participation and provided written informed consent at the start of each interview.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}],"article-number":"21"}}